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Objectives: The aim of this meta-analysis is to assess the association between obesity and risk of surgical
site infections (SSI) risk in orthopedics.
Methods: We searched the electronic database of PubMed and Web of Science for observational studies
about risk factors for SSI risk in orthopedics, meta-analysis of body mass index (BMI) between infection
group and no infection group, infection rate in obesity expose and no obesity expose were conducted,
respectively.
Results: A total of 20 studies included in the meta-analysis. The pooled weighted mean difference (WMD)
of BMI between infection group and no infection group was 0.329 (95% CI 0.215e0.444), which was
statistically signiﬁcant (z ¼ 5.65, p ¼ 0.000). The pooled relative risk (RR) of infection rate compare
obesity expose with no obesity expose was 1.915 (95% CI 1.530e2.396), which was statistically signiﬁcant
(z ¼ 5.68, p ¼ 0.000). No publication bias was found (Begg test P ¼ 0.174 and Egger test P ¼ 0.345) in
pooled WMD of BMI. But there was signiﬁcant publication bias in pooled RR of infection rate (Begg test
P ¼ 0.001 and Egger test P ¼ 0.001).
Conclusion: Our meta-analysis indicates that obesity had about twofold increased risk of surgical site
infections risk in orthopedics. However, this conclusion should be veriﬁed by further well designed
prospective cohort studies.
 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction charges (1.76 times for hips surgery and 1.52 times for knees sur-Surgical site infection (SSI) is one of the most common compli-
cations following orthopedic surgery. Based on the most recent
report, the overall total SSI rate after spine surgery was 2.1%
(superﬁcial ¼ 0.8%, deep ¼ 1.3%), for adults ranged from 1.4% for
degenerative disease to 4.2% for kyphosis, and for pediatric patients
ranged from 0.9% for degenerative disease to 5.4% for kyphosis.1 For
arthroplasty operation, a systematic review indicated the incidence
of SSI after total hip arthroplasty ranged from 0.2% before discharge
to1.1% for theperiodup to and including5years post surgery.2While
in total knee arthroplasty, the ratesof superﬁcial andprosthetic joint
infections were 2.9% and 0.80%, respectively.3 The SSI was also
founded in internal ﬁxation of fracture, revision arthroplasty, and
deformityoperation.4e6 TheSSI signiﬁcantlyprolonged the lengthof
stay (9.7 days for hip surgery and 7.6 days for knee surgery in un-
infectedproceduresVs. 4.3 days surgery forhip and3.9 days for knee
surgery in infected procedures), increased the hospitalizationdics, The Second Afﬁliated
Province 215000, PR China.
ciates Ltd. Published by Elsevier Ltgery).7 Another study showedSSIwas a strongpredictorofmortality
(odds ratio ¼ 3.80; 95% conﬁdence interval ¼ 1.49, 9.70).8 It is very
important for reducing the risk factors for SSI prevention.
Many studies have investigated the risk factors for orthopedic SSI.
OlsenMAet al. identiﬁed SSI risk factors for spinal operation included
diabetes, suboptimal timing of prophylactic antibiotic therapy, a
preoperative serum glucose level of >125 mg/dL (>6.9 mmol/L) or a
postoperative serumglucose level of>200mg/dL, obesity, and twoor
more surgical residents participating in the operative procedure.9
Fang A et al. also identiﬁed age >60 years, smoking, diabetes, previ-
ous surgical infection, increased body mass index, and alcohol abuse
were statistically signiﬁcantpreoperative risk factors for SSI following
spinal surgery.10 For hemiarthroplasties and total hip arthroplasties,
Cordero-Ampuero J et al. found SSI risk factors included female
gender, previous surgery, obesity, glucocorticoid and immunosup-
pressant treatments, prolonged surgical time, inadequate antibiotic
prophylaxis, prolongedwound drainage, hematoma, dislocation, and
cutaneous, urinary, and/or abdominal infections.11Many studies have
found obesity was the important risk factors for orthopedic SSI. But
the literature havenot been reviewed systematically for risk factors of
obesity, and the risk effect size is still unknown.d. All rights reserved.
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is associated with SSI risk in orthopedics, and establish the best
estimate of the impact. In this meta-analysis, we deﬁned obesity as
BMI30 kg/m2 according to WHO.12
2. Methods
2.1. Databases and literature search
We searched MEDLINE (PubMed, http://www.ncbi.nlm.nih.gov/pubmed/),
and Web of Science (http://webofknowledge.com/) up to 5 July 2012. The
search terms included of “obesity”, “body mass” and “infection”. The search
detail in MEDLINE was (Etiology/Broad[ﬁlter]) and (“obesity” [tiab] or “body
mass” [tiab]) and “infection” [tiab] and (“spine” [tiab] or “hip” [tiab] or “knee”
[tiab] or “joint” [tiab] or “fracture” [tiab] or “arthroplasty” [tiab] or “orthope-
dics” [tiab]). In Web of Science, the search detail used as follows: (Ts ¼ obesity
or Ts¼ (body mass)) and Ts ¼ infection and Ts ¼ risk, and reﬁned by: subject
areas¼ (orthopedics). We supplemented our searches by manually reviewing
the references of all relevant studies. Only studies published in English were
included.
2.2. Eligibility criteria
The following inclusion criteria had to be fulﬁlled: 1) observational studies
(cross-sectional, caseecontrol, or cohort study) that assessed the causal association
between obesity and surgical site infections risk in orthopedics; 2) obesity was clear
deﬁnite according to WHO (BMI  30 kg/m2); 3) Reported mean  standard de-
viation of BMI with sample size between infection group and non-infection group;
or reported relative risk (RR) with 95% conﬁdence interval (CI) of infection risk
between two groups, or providing sufﬁcient data to construct the two-by-two
contingency tables to calculate RR. We excluded case reports, case series, and
reviews.
2.3. Data extraction and critical appraisal
The following data were abstracted onto standardized forms: ﬁrst author,
publication year, country, study design, age of included patients, year of operation,
type of surgery, time of infection, and BMI mean  standard deviation or number of
patients in case or control group.
The quality of articles was assessed according to the NewcastleeOttawa Scale
(NOS).13 The NOS contains eight items, categorized into three dimensions including
Selection (4), Comparability (1), and Exposure (3). A high quality study can be
awarded a maximum of one star for each numbered item within the Selection and
Exposure categories. A maximum of two stars can be given for Comparability. The
NOS ranges between zero up to nine stars.211 citations were identified in PubMed 
24 non-English articles were deleted 
9 reviews were deleted 
152  studies did not meet the 
inclusion criteria were deleted 
17 studies were usable for meta-analysis 
20 studies were usable for 
9 case reports were deleted 
19 studies were usable after excluded 11 
duplicate studies 
Fig. 1. Flow diagram showi2.4. Statistical analysis
For continuous variable, pooled weighted mean difference (WMD) with 95% CI
was calculated for each measurement. For dichotomous variable, pooled RR with
95% CI was calculated for each measurement. Overall effects were determined using
the Z test. Statistical heterogeneity was explored by c2 and inconsistency (I2) sta-
tistics; an I2 value of 50 percent or more represented substantial heterogeneity.14 In
the absence of signiﬁcant heterogeneity, studies were pooled using a ﬁxed-effect
model. If heterogeneity was observed, a random-effects model was used. Sub-
group analysis was conducted on type of surgery, and sensitivity analysis was
conducted by changing analyze model. Visual inspection of a funnel plot, the Egger
regression test, and Begg adjusted rank correlation test were performed to assess
publication bias. All statistical analyzes were performed with Stata software, version
12.0 (Stata Corp, College Station, Texas). Two-sided P < 0.050 was considered sta-
tistically signiﬁcant.
3. Results
3.1. Characteristics of included studies
We identiﬁed 20 studies that met our inclusion criteria for
meta-analysis.6,9,11,15e31 The detailed steps of our literature search
are shown in Fig. 1. The studies included 6 cohort studies, 14 case-
control studies. Of these studies, twelve were conducted in United
States, four in Australia, two in Spain, one in United Kingdom, and
one in Japan. These articles were published between the years
2003e2012. The surgical operations were included: total hip
arthroplasty (THA), total knee arthroplasty (TKA), spine fusions,
spinal deformity surgery, total knee revision arthroplasty, and
acetabular fracture ﬁxation. The operations were conducted in
1991e2011. The quality rating of the included studies ranged from
six to eight stars on the scale of nine. Table 1 and Table 2 shows the
characteristics of the 20 identiﬁed studies.
3.2. Main meta-analysis
3.2.1. BMI difference between infection group and no infection
group
Eight studies18,24,26e31 providing usable BMI data between
infection group and no infection group were included for analysis
(Table 1). Heterogeneity estimation by c2 test provided a P value of1 study was added by manually reviewing 
conference proceedings and references 
meta-analysis 
2,571 citations were identified in Web of Science 
85 citations were identified refined by orthopedics 
4 non-English articles were deleted 
5 reviews were deleted 
63 studies did not meet the inclusion criteria 
were deleted 
13 studies were usable for meta-analysis 
ng selection of studies.
Table 1
Characteristics of selected studies for continuous variable meta-analysis.
First author, Year Country Study design Age Year of
operation
Time of
infection
Type of surgery Infection group No infection group NOS
(※)
N BMI
(mean  SD)
N BMI
(mean  SD)
Malinzak RA, 200918 USA Case-control 68.8  10.2 1991e2004 9.6 months
(13.5 weeks)
TKA and THA 43 32.8  8.8 8451 30.0  5.7 7
Cizik AM, 201224 USA Cohort Mean
49.4e53.5
Jan 1, 2003e
Dec 31,2004
at least
two years
Spine surgery 63 28.8  8.0 1469 27.6  6.4 8
Suzuki G, 201126 Japan Case-control 72 (26e91) 1995e2006 42 (6e145)
months
Total knee
arthroplasty
17 27.4  5.5 2005 25.6  4.1 8
Peel TN, 201127 Australia Case-control Mean 68-69 1 Jan 2000e31
Jan 2007
54 (5e277)
days
Knee or hip
replacements
27 33.0  6.9 54 32.4  6.4 8
O’Neill KR,201128 USA Case-control Mean 43e45 Jan 2008e
Dec 2009
2-year Posterior Spine
Fusions
56 30  11 54 27  6 8
Mraovic B,201129 USA Case-control Mean 62e64 2000e2008 2 year Total hip and
knee arthroplasty
101 32  9 1847 30  7 7
Suzuki T, 201030 USA Case-control 42.9  18.1 Jan 2001e
Dec 2007
30 days Acetabular
fracture ﬁxation
17 33.0  9.2 309 26.9  6.2 7
Ghanem E, 200731 USA Cohort Mean 66e68 Oct 2003e
Aug 2004
Average of
25 months
Total knee
revision
arthroplasty
22 34  12 84 32  6 7
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ﬁxed-effect model, the pooled WMD was 0.329 (95% CI 0.215e
0.444), which was statistically signiﬁcant (z ¼ 5.65, p ¼ 0.000)
(Fig. 2). In arthroplasty surgery subgroup, the pooled WMD was
0.322 (95% CI 0.180e0.464, z ¼ 4.45, p ¼ 0.000). In spine surgery
subgroup, the pooled WMD was 0.232 (95% CI 0.023e0.442,
z ¼ 2.17, p ¼ 0.030). In acetabular fracture ﬁxation subgroup, the
pooled WMD was 0.956 (95% CI 0.462e1450, z ¼ 2.17, p ¼ 0.000)
(Fig. 2).Table 2
Characteristics of selected studies for dichotomous variable meta-analysis.
First author,
Year
Country Study design Age Year of operation
Bozic KJ, 201215 USA Case-control >65 1998e2007
Koutsoumbelis S,
201116
USA Case-control Mean
56.9e61.0
Jan 2000eDec 2006
Font-Vizcarra L,
201117
Spain Cohort 65.06  13.87 Mar 2007eMar 2011
Cordero-Ampuero J,
201011
Spain Case-control Mean 67e84 Jan 1997eDec 2007
Pull ter Gunne AF,
20106
USA Case-control 55.4  16.1 Jun 1996eDec 2005
Dowsey MM,
200819
Australia Case-control 72 (65e77) Jan 1998eDec 2005
Pull ter Gunne AF,
200920
USA Case-control 55.6  15.5 Jun 1996eDec 2005
Chesney David,
200821
United
Kingdom
Cohort Mean 64-75 Oct 1998eFeb 2005
Dowsey MM,
200822
Australia Case-control 69 (18e97) Jan 1998eDec 2005
Olsen MA, 20089 USA Case-control 52.4 (15.2e94.4) 1998e2002
Olsen MA, 200323 USA Case-control Not mentioned 1996e1999
Cizik AM, 201224 USA Cohort Mean 49.4e53.5 Jan 1, 2003e
Dec 31,2004
Choong PF, 200725 Australia Cohort 68 (18e96) Jan 1998eApr 20043.3. Infection rate in obesity expose and no obesity expose
Thirteen studies6,9,11,15e17,19e25 providing usable infection rate
data in obesity expose and no obesity expose were included for
analysis (Table 2). Heterogeneity estimation by c2 test provided a
P value of 0.000 and I2 ¼ 72.5% indicating signiﬁcant heteroge-
neity. The infection rate was 5.7% (440/7742) in obesity group and
4.4% (3869/88200) in no obesity group. By using random-effects
model, the pooled RR was 1.915 (95% CI 1.530e2.396), whichTime of
infection
Type of surgery Infection No infection NOS
(※)
Obesity No
obesity
Obesity No
obesity
90-day
postoperative
TKA 185 4796 2106 75924 8
Not mentioned Posterior lumbar
instrumented
arthrodesis
36 48 12 156 8
3 months after
joint arthroplasty
Hip arthroplasty 14 10 141 188 8
More than 3
months
after surgery
Hemiarthroplasties 2 21 1 99 7
Total hip
arthroplasties
8 16 19 81
At least 1 year Spinal deformity
surgery
7 39 47 737 7
1 year after TKA TKA 14 701 4 495 7
At least 1 year Spinal surgery 15 117 220 2822 7
5 year Knee arthroplasty 36 532 28 682 8
Acute infection Hip arthroplasty
(without diabetes
comorbidity)
12 380 5 677 7
Hip Arthroplasty
(without cardiac
comorbidity)
5 122 2 342
Hip Arthroplasty
(Hardinge approach)
9 318 6 521
Hip Arthroplasty
(Posterior approach)
6 129 1 217
5 year Spinal operation 26 20 65 161 7
4 year Spinal operation 17 24 49 127 6
at least
two years
Spine surgery 38 25 874 595 7
1 year after hip
replacement
Hip replacement
surgery
10 4 289 516 7
Heterogeneity between groups: p = 0.030
Overall  (I-squared = 30.4%, p = 0.186)
Subtotal  (I-squared = .%, p = .)
Suzuki G,2011
ID
Cizik AM, 2012
Study
Spine Surgery
Subtotal  (I-squared = 0.0%, p = 0.512)
Suzuki T, 2010
Acetabular Fracture Fixation
Subtotal  (I-squared = 0.0%, p = 0.626)
O'Neill KR,2011
Mraovic B,2011
Arthroplasty
Malinzak RA,2009
Peel TN,2011
Ghanem E, 2007
0.33 (0.22, 0.44)
0.96 (0.46, 1.45)
0.44 (-0.04, 0.92)
SMD (95% CI)
0.19 (-0.07, 0.44)
0.23 (0.02, 0.44)
0.96 (0.46, 1.45)
0.32 (0.18, 0.46)
0.34 (-0.04, 0.71)
0.28 (0.08, 0.48)
0.49 (0.19, 0.79)
0.09 (-0.37, 0.55)
0.26 (-0.21, 0.73)
100.00
5.36
5.73
Weight
20.55
%
29.78
5.36
64.86
9.23
32.54
14.56
6.12
5.90
-1.45 0 1.45
Fig. 2. Forest plot of pooled BMI WMD between infection group and no infection group (by ﬁxed-effect model).
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ORIGINAL RESEARCHwas statistically signiﬁcant (z ¼ 5.68, p ¼ 0.000) (Fig. 3). In
arthroplasty surgery subgroup, the infection rate was 4.1% (301/
7330) in obesity group and 3.2% (2602/82344) in no obesity
group; the pooled RR was 1.818 (95% CI 1.431e2.310, z ¼ 4.89,NOTE: Weights are from random effects analysis
Overall  (I-squared = 72.5%, p = 0.000)
Olsen MA, 2008
Dowsey MM, 2008 (without cardiac comorbidity)
Koutsoumbelis S, 2011
Dowsey MM, 2008
Font-Vizcarra L, 2011
ID
Olsen MA, 2003
Dowsey MM, 2008 (Posterior approach)
Cordero-Ampuero J,2010 (Hemiarthroplasties)
Spinal Surgery
Dowsey MM, 2008 (Hardinge approach)
Chesney David, 2008
Cizik AM, 2012
Pull ter Gunne AF, 2010
Pull ter Gunne AF, 2009
Dowsey MM, 2008 (without diabetes comorbidity)
Cordero-Ampuero J,2010 (THA)
Choong PF, 2007
Study
Subtotal  (I-squared = 88.0%, p = 0.000)
BozicKJ,2012
arthroplasty
Subtotal  (I-squared = 44.8%, p = 0.053)
.0109
Fig. 3. Forest plot of pooled RR of infection rate in obesity exp ¼ 0.000). In spine surgery subgroup, the infection rate was 33.7%
(139/412) in obesity group and 21.6% (1267/5865) in no obesity
group; the pooled RR was 1.950 (95% CI 1.211e3.141, z ¼ 2.75,
p ¼ 0.006) (Fig. 3).1.91 (1.53, 2.40)
1.97 (1.42, 2.72)
6.77 (1.33, 34.46)
6.00 (3.30, 10.92)
2.44 (0.81, 7.38)
1.36 (0.95, 1.95)
RR (95% CI)
1.49 (0.96, 2.30)
9.69 (1.18, 79.60)
8.70 (0.82, 91.84)
2.42 (0.87, 6.73)
1.61 (0.99, 2.60)
1.01 (0.83, 1.24)
2.54 (1.22, 5.30)
1.57 (0.96, 2.57)
4.18 (1.48, 11.76)
1.75 (0.88, 3.52)
1.99 (1.41, 2.81)
1.95 (1.21, 3.14)
1.38 (1.19, 1.59)
1.82 (1.43, 2.31)
100.00
9.06
1.62
6.23
3.01
8.69
Weight
7.89
1.03
0.84
3.36
7.39
10.26
5.08
7.27
3.30
5.39
8.87
%
45.79
10.69
54.21
1 91.8
pose and no obesity expose (by random-effects model).
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For BMI WMD meta-analysis, the funnel plot was symmetrical,
and either the Begg test (P ¼ 0.174) or the Egger test (P ¼ 0.345)
suggested no publication bias (Fig. 4, Right). But for infection rate
meta-analysis, the funnel plot was asymmetric, and either the Begg
test (P ¼ 0.002) or the Egger test (P ¼ 0.001) suggested signiﬁcant
publication bias (Fig. 4, Left).
3.5. Sensitivity analysis
For BMI WMD meta-analysis, when using random-effects
model, the pooled WMD was 0.345 (95% CI 0.199e0.491), which
was statistically signiﬁcant (z ¼ 4.64, p ¼ 0.000). For infection rate
meta-analysis, when using ﬁxed-effect model, the pooled RR was
1.556 (95% CI 1.413e1.713), which was statistically signiﬁcant
(z ¼ 8.99, p ¼ 0.000).
4. Discussion
Our meta-analysis showed obesity had about twofold increased
risk of SSI (the pooled RR was 1.915, 95% CI 1.530e2.396), and
sensitivity analysis still showed the statistically signiﬁcant of the
pooled RR, which indicated the result is robust. Some studies have
investigated the pathophysiological basics of the relationship be-
tween obesity and infection. Nishimura S et al. found that large
numbers of CD8(þ) effector T cells inﬁltrated obese epididymal
adipose tissue in mice fed a high-fat diet, whereas the numbers of
CD4(þ) helper and regulatory T cells were diminished, which
suggest that obese adipose tissue activates CD8(þ) T cells.32
O’Rourke RW et al. found alterations in peripheral blood lympho-
cyte cytokine expression in obesity: serum IL-1beta was unde-
tectable, IL-1Ra serum levels were elevated, serum levels of TNF-
alpha were decreased and serum levels of IL-6 were similar in
obese subjects compared to lean subjects, while transcript levels of
IL-6, IL-1beta and TNF-alpha, but not IL-1Ra, were decreased.33 The
adipose tissue participates actively in inﬂammation and immunity
maybe the mechanisms that predispose obese patients to infec-
tion.34 In surgical operation, obesity will increase in local tissue
trauma related to retraction, lengthened operative time, and
disturbance of body homeostatic balance. Thesemay be some other
reason contributing to the increased incidence of SSI in patients
with obesity. Obesity related to SSI was also found in other types of
surgery. Okabayashi T et al. reported, in hepatic resection surgery,
BMI > 23.6 kg/m2 was a risk factor for SSI with the OR 3.7 (95% CI
1.2e11.2; P ¼ 0.019]).35 Hourigan JS et al. reviewed the articles for
abdominal surgery, and found obesity increased the risk of SSI as0
.
05
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1
.
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.
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Funnel plot with pseudo 95% confidence limits
Fig. 4. Funnel plot for publication bias. Right panel showed symmetrical which suggested
which suggested signiﬁcant publication bias for infection rate meta-analysis.high as sixty percent.36 In coronary artery bypass grafting surgery,
SharmaM et al. found BMI>30 kg/m2 was independent risk factors
for SSI with the OR 3.00 (95% CI 1.53e5.89, P ¼ 0.001) in multi-
variate analysis.37
Our meta-analysis showed some heterogeneity between
included studies, especially for pooled RR of infection rate in
obesity expose and no obesity expose. Except obesity, many factors
can affect the incidence of SSI, such as female gender, old age,
smoking, diabetes, previous surgical infection, alcohol abuse, pro-
longed surgical time, inadequate antibiotic prophylaxis, prolonged
wound drainage, hematoma, dislocation, and cutaneous, urinary,
and/or abdominal infections. The sources of heterogeneity came
form inconsistent factors between the included studies. Most of the
studies accessed the adjusted RR by multivariate analysis. But we
can’t use the adjusted RR for the meta-analysis, for sufﬁcient data
can’t be extracted to construct two-by-two contingency tables by
adjusted RR. But after we investigated the articles existing het-
erogeneity, we found some of the studies have the positive
conclusion that obesity was one of the risk factors of SSI in ortho-
pedics by adjusted RR, while the unadjusted RR was no statistically
signiﬁcant in our meta-analysis.17,22,24 These results further
increased the credibility of conclusion that obesity was related to
SSI in orthopedics.
According to the data of National Health and Nutrition Exami-
nation Survey (NHANES) in 2007e2008, the age-adjusted preva-
lence of obesity among US adults was 33.8% (95% CI, 31.6%e36.0%)
overall, 32.2% (95% CI, 29.5%e35.0%) amongmen, and 35.5% (95% CI,
33.2%e37.7%) among women. The corresponding prevalence esti-
mates for overweight and obesity combined (BMI >¼ 25) were
68.0% (95% CI, 66.3%e69.8%), 72.3% (95% CI, 70.4%e74.1%), and
64.1% (95% CI, 61.3%e66.9%).38 The prevalence of obesity has
signiﬁcantly increased over the past 30 years. Therefore, orthopedic
surgeons should pay particular attention to obese patients. Some
conventional treatment should be performed before surgery to
prevent SSI in orthopedics.
There are some limitations in this meta-analysis. First, signiﬁ-
cant publication bias was found in this meta-analysis. We only
searched through English-language reports, and searched in
two electronic databases, it may have missed studies in our liter-
ature review. Another reason may be that some studies were
excluded because they can not extract the data, but these studies
have positive conclusion that obesity related to SSI risk in ortho-
pedics.3,39e41 Second, most of the included studies were retro-
spective caseecontrol studies, which are more prone to bias. It is
clear that well designed prospective cohorts are needed.
In conclusion, our meta-analysis found the evidence of an as-
sociation between the obesity and surgical site infections risk in0
.
5
1
se
(lo
gR
R
)
0 2 4 6 8 10
RR
Funnel plot with pseudo 95% confidence limits
no publication bias for BMI WMD meta-analysis, while left panel showed asymmetric
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ORIGINAL RESEARCHorthopedics surgery. It has about twofold increased risk of surgical
site infections risk in orthopedics. However, this conclusion should
be veriﬁed by further well designed prospective cohort studies.
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